Vascular Diseases

0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Francis Medical
Francis MedicalMN - Maple Grove
1 program
ElucidVivoN/A1 trial
Active Trials
NCT05524896CompletedEst. Jul 2022
LeMaitre Vascular
LeMaitre VascularAustralia - Docklands
1 program
Implant the XenoSure patchN/A1 trial
Active Trials
NCT03173703Active Not RecruitingEst. Nov 2025
Artivion
ArtivionKENNESAW, GA
1 program
PhotoFixN/A1 trial
Active Trials
NCT03669042CompletedEst. Jul 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
ArtivionPhotoFix
LeMaitre VascularImplant the XenoSure patch
Francis MedicalElucidVivo

Clinical Trials (3)

NCT03669042ArtivionPhotoFix

Post-market, Prospective Evaluation of PHOTO-oxidized Bovine Pericardium in Vascular Surgery

Start: Nov 2018Est. completion: Jul 2020
N/ACompleted
NCT03173703LeMaitre VascularImplant the XenoSure patch

Evaluate Safety and Effectiveness of XenoSure® Biological Patch in the Application of Peripheral Vascular Repair

Start: Jul 2017Est. completion: Nov 2025
N/AActive Not Recruiting
NCT05524896Francis MedicalElucidVivo

Elucidate Vasodilatory Capacity From Histology-Defined Analysis of Coronary CT Angiography

Start: Jan 2017Est. completion: Jul 2022
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space